Teva Pharmaceutical Industries Ltd.

Israël

Retour au propriétaire

1-100 de 762 pour Teva Pharmaceutical Industries Ltd. et 1 filiale Trier par
Recheche Texte
Excluant les filiales
Affiner par Reset Report
Type PI
        Brevet 443
        Marque 319
Juridiction
        International 411
        Europe 158
        États-Unis 102
        Canada 91
Propriétaire / Filiale
[Owner] Teva Pharmaceutical Industries Ltd. 762
Teva Pharmaceuticals USA, Inc. 332
Date
2025 (AACJ) 17
2024 28
2023 11
2022 10
2021 16
Voir plus
Classe IPC
A61K 9/20 - Pilules, pastilles ou comprimés 49
A61K 31/135 - Amines, p. ex. amantadine ayant des cycles aromatiques, p. ex. méthadone 23
A61K 31/47 - QuinoléinesIsoquinoléines 20
A61K 9/16 - AgglomérésGranulésMicrobilles 19
A61K 31/4704 - 2-Quinolones, p. ex. carbostyrile 16
Voir plus
Classe NICE
05 - Produits pharmaceutiques, vétérinaires et hygièniques 246
35 - Publicité; Affaires commerciales 47
44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture. 36
10 - Appareils et instruments médicaux 33
42 - Services scientifiques, technologiques et industriels, recherche et conception 31
Voir plus
Statut
En Instance 42
Enregistré / En vigueur 720
  1     2     3     ...     8        Prochaine page

1.

teva Rise

      
Numéro d'application 019183670
Statut En instance
Date de dépôt 2025-05-07
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Business consulting and advisory services in the fields of innovation, organizational change, and strategic growth; business consultancy services, namely, organizing innovation challenges to identify and implement operational improvements; promoting collaboration with startups to facilitate innovation and improve operational efficiency; business networking services for connecting business with startup companies; business management and coordination of pilot testing programs with startup companies; business consultancy services for facilitating collaboration between enterprises and external innovation partners for business purposes. Educational Services, namely, conducting workshops, seminars, and training programs in the field of healthcare innovations and leadership; training and education services relating to leadership development programs to support innovation and organizational transformation; providing mentorship and career development services in the field of innovation and healthcare technology; organizing business competitions to identify and implement operational improvements. Hosting an open innovation platform connecting researchers, startups, companies, and business organizations to develop and implement innovative business strategies and solutions; Software as a services (SaaS) for managing innovation process, including internal challenge collection, startup sourcing, and pilot testing coordination; providing temporary use of non-downloadable software for facilitating collaboration between enterprises and startups; technology consultation in the field enterprise innovation systems and startup integration.

2.

TEVA RISE

      
Numéro d'application 239547300
Statut En instance
Date de dépôt 2025-04-29
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Business consulting and advisory services in the fields of innovation, organizational change, and strategic growth; organizing business competitions and innovation challenges to identify and implement operational improvements; promoting collaboration with startups to facilitate innovation and improve operational efficiency; business networking services for connecting business with startup companies; business management and coordination of pilot testing programs with startup companies; facilitating collaboration between enterprises and external innovation partners for business purposes. (2) Educational Services, namely, conducting workshops, seminars, and training programs in the field of healthcare innovations and leadership; leadership development programs to support innovation and organizational transformation; providing mentorship and career development services in the field of innovation and healthcare technology. (3) Providing an online open innovation platform connecting researchers, startups, companies, and business organizations to develop and implement innovative business strategies and solutions; Software as a services (SaaS) for managing innovation process, including internal challenge collection, startup sourcing, and pilot testing coordination; providing temporary use of non-downloadable software for facilitating collaboration between enterprises and startups; technology consultation in the field enterprise innovation systems and startup integration.

3.

OMZYRLI

      
Numéro d'application 019179268
Statut Enregistrée
Date de dépôt 2025-04-28
Date d'enregistrement 2025-08-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

4.

OMZYRLI

      
Numéro de série 99158471
Statut En instance
Date de dépôt 2025-04-28
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

5.

OMZYRLI

      
Numéro d'application 239500000
Statut En instance
Date de dépôt 2025-04-25
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

6.

QLEERVI

      
Numéro d'application 239404400
Statut En instance
Date de dépôt 2025-04-23
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma. Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

7.

QLEERVI

      
Numéro d'application 019175936
Statut Enregistrée
Date de dépôt 2025-04-22
Date d'enregistrement 2025-08-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

8.

KLIRUVEI

      
Numéro de série 99143811
Statut En instance
Date de dépôt 2025-04-18
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

9.

OMKALRI

      
Numéro d'application 239328200
Statut En instance
Date de dépôt 2025-04-17
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

10.

KLIRUVEI

      
Numéro d'application 239327600
Statut En instance
Date de dépôt 2025-04-17
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

11.

KLIRUVEI

      
Numéro d'application 019175061
Statut Enregistrée
Date de dépôt 2025-04-17
Date d'enregistrement 2025-08-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

12.

QLEERI

      
Numéro d'application 019175083
Statut Enregistrée
Date de dépôt 2025-04-17
Date d'enregistrement 2025-08-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

13.

YULIZBRI

      
Numéro d'application 019175085
Statut Enregistrée
Date de dépôt 2025-04-17
Date d'enregistrement 2025-08-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

14.

YULIZBRI

      
Numéro d'application 239328400
Statut En instance
Date de dépôt 2025-04-17
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

15.

OMKALRI

      
Numéro d'application 019175062
Statut Enregistrée
Date de dépôt 2025-04-17
Date d'enregistrement 2025-08-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

16.

EMRUSOLMIN FOR USE IN TREATING MULTIPLE SYSTEM ATROPHY

      
Numéro d'application IB2024059428
Numéro de publication 2025/068949
Statut Délivré - en vigueur
Date de dépôt 2024-09-26
Date de publication 2025-04-03
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Giese, Armin
  • Levin, Johannes
  • Izgelov, Dvora
  • Perlstein, Itay
  • Chen, Maria
  • Knebel, Helena
  • Singh, Rajendra Pratap
  • Grossman, Moran
  • Magid, Lital
  • Rubinstein, Efrat
  • Ahn, Andrew
  • Barash, Steve
  • Cicali, Brian
  • Schmidt, Stephan

Abrégé

The disclosure provides methods of stabilizing one or more symptoms of Multiple System Atrophy (MSA), limiting the clinical progression of MSA, slowing the clinical progression of MSA, o stabilizing the clinical progression of MSA in a human or population of humans in need thereof, comprising orally administering, on a daily basis, of 300 mg emrusolmin to the human or humans. The disclosure also provide methods of improving overall survival in a human with MSA, improving progress-free survival in a human with MSA, or treating a human having Multiple System Atrophy (MSA) and in need of treatment thereof, comprising orally administering about 300 mg of emrusolmin to the human.

Classes IPC  ?

  • A61K 31/4155 - 1,2-Diazoles non condensés et contenant d'autres hétérocycles
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence

17.

METHODS AND SYSTEMS FOR DETECTING THE PROGRESSION OF A MOVEMENT DISORDER

      
Numéro d'application IL2024050950
Numéro de publication 2025/069021
Statut Délivré - en vigueur
Date de dépôt 2024-09-26
Date de publication 2025-04-03
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Melamed, Michal
  • Rorabaugh, Jacki
  • Reich, Michael
  • Giese, Armin
  • Levin, Johannes
  • Chen, Maria
  • Ahn, Andrew
  • Barash, Steve
  • Knebel, Helena
  • Izgelov, Dvora

Abrégé

A method for detecting the progression of multiple system atrophy (MSA) over a time period using a trained machine learning model for a patient with MSA. The method may include receiving in-clinic sensor data and at-home sensor data for a patient over the time period. The method may include determining respective values indicative of a plurality of different MSA-related activity features for the patient based on the in-clinic sensor data and the at-home sensor data. The method may further include determining, using the trained machine learning model, the progression of MSA over the time period for the patient using the respective values for the plurality of different MSA-related activity features for the patient.

Classes IPC  ?

  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

18.

teva

      
Numéro d'application 1829733
Statut Enregistrée
Date de dépôt 2024-09-10
Date d'enregistrement 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

19.

teva

      
Numéro d'application 1829823
Statut Enregistrée
Date de dépôt 2024-09-08
Date d'enregistrement 2024-09-08
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

20.

teva

      
Numéro d'application 1829735
Statut Enregistrée
Date de dépôt 2024-09-10
Date d'enregistrement 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

21.

teva

      
Numéro d'application 1829734
Statut Enregistrée
Date de dépôt 2024-09-10
Date d'enregistrement 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

22.

teva

      
Numéro d'application 1829736
Statut Enregistrée
Date de dépôt 2024-09-10
Date d'enregistrement 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations.

23.

XOZYRLI

      
Numéro d'application 236153700
Statut En instance
Date de dépôt 2024-11-12
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

24.

AERYLFI

      
Numéro d'application 236154200
Statut En instance
Date de dépôt 2024-11-12
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

25.

HUMANIZING HEALTH AWARDS

      
Numéro de série 98842546
Statut En instance
Date de dépôt 2024-11-07
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Conducting incentive award programs for Non-Governmental Organization employees to support and promote healthcare job initiatives to enhance quality of patient and caregiver experience Providing a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

26.

XOZIRLI

      
Numéro d'application 019091345
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

27.

AERYLFI

      
Numéro de série 98802102
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

28.

VEXLAYRI

      
Numéro de série 98802329
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

29.

XOZYRLI

      
Numéro d'application 019091206
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

30.

AERYLFI

      
Numéro d'application 019091251
Statut Enregistrée
Date de dépôt 2024-10-15
Date d'enregistrement 2025-02-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

31.

XOZURRI

      
Numéro d'application 019091290
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

32.

OMKLYNI

      
Numéro d'application 019091348
Statut Enregistrée
Date de dépôt 2024-10-15
Date d'enregistrement 2025-02-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

33.

VEXLAYRI

      
Numéro d'application 019091477
Statut Enregistrée
Date de dépôt 2024-10-15
Date d'enregistrement 2025-02-14
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders; pharmaceutical preparations for the prevention and treatment of central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies.

34.

OMKLYNI

      
Numéro de série 98802322
Statut En instance
Date de dépôt 2024-10-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders, pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations; pharmaceutical preparations for the treatment of asthma, chronic rhinosinusitis, chronic spontaneous urticaria, and food allergies

35.

Nous avons tous à coeur d'améliorer la santé

      
Numéro d'application 235302500
Statut En instance
Date de dépôt 2024-10-01
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Human pharmaceutical preparations. (1) Research services in the field of human pharmaceuticals. (2) Medical services for humans; human healthcare services; consulting services in the field of human pharmaceuticals.

36.

We are all in for better health

      
Numéro d'application 235302200
Statut En instance
Date de dépôt 2024-10-01
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Human pharmaceutical preparations. (1) Research services in the field of human pharmaceuticals. (2) Medical services for humans; human healthcare services; consulting services in the field of human pharmaceuticals.

37.

TEVA

      
Numéro d'application 237094700
Statut En instance
Date de dépôt 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations.

38.

TEVA

      
Numéro d'application 237094600
Statut En instance
Date de dépôt 2024-09-10
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations.

39.

MOVEMENT DISORDER DETECTION AND ASSESSMENT

      
Numéro d'application IL2024050156
Numéro de publication 2024/166115
Statut Délivré - en vigueur
Date de dépôt 2024-02-09
Date de publication 2024-08-15
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Reich, Michael
  • Gotler, Alex
  • Efrati, Itamar

Abrégé

The present disclosure relates to systems and methods for assessing severity of involuntary movement associated with tardive dyskinesia (TD). The method includes receiving video data of the patient. The video data may include facial movements of the patient. The method includes processing the video data to identify facial landmark data of the patient, which may include applying an image processing technique to the video data to identify facial landmarks on one or more frames of the video data to produce labeled frames. The method may include applying a plurality of trained machine learning models to the facial landmark data to determine one or more movement severity scores based on changes in the facial landmark data of the patient, where each movement severity score is representative of a category of facial movement, and a total severity score may be generated based on multiple movement severity scores.

Classes IPC  ?

  • A61B 5/11 - Mesure du mouvement du corps entier ou de parties de celui-ci, p. ex. tremblement de la tête ou des mains ou mobilité d'un membre
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

40.

EMPTYING MONITORING SYSTEM FOR GASTROINTESTINAL TRACT DEVICES

      
Numéro d'application IB2023063144
Numéro de publication 2024/134599
Statut Délivré - en vigueur
Date de dépôt 2023-12-21
Date de publication 2024-06-27
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Llan

Abrégé

Disclosed herein are apparatus, system, and method aspects for monitoring emptying of a retentive device from a predetermined location of a gastrointestinal tract. An aspect includes an expandable platform (100) used to dispense a medication at the predetermined location of the gastrointestinal tract that includes an emptying monitoring indicator that provides information on emptying of the expandable platform from the predetermined location. The expandable platform may include at least two articulating arms (102-n), a first and a second coupling head (104), a deformable member (106), and a locking assembly (212) that together allow the expandable platform to exist among various configurations. Additional aspects include a receiver (502) and/or a mobile device (504) for receiving a signal from the sensor and providing patient instructions accordingly.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

41.

TEVA

      
Numéro de série 98581718
Statut En instance
Date de dépôt 2024-06-03
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Training services for pharmacists in the field of pharmacy; educational services, namely conducting online classes and seminars for pharmacists in the field of neurology, cancer, respiratory diseases and women's health.

42.

RETENTIVE DEVICES FOR GASTROINTESTINAL TRACT

      
Numéro d'application 18548915
Statut En instance
Date de dépôt 2022-03-02
Date de la première publication 2024-05-02
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

A device for temporary residence at a predetermined location of the gastrointestinal tract of a subject is described. The device transfers from a closed configuration into an expanded configuration. The device is retained at the predetermined location and transfers from the expanded configuration into an emptying configuration in which the device moves past the predetermined location. The device enables localized medical methods in the gastrointestinal tract of the subject.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

43.

TEVA

      
Numéro de série 98437912
Statut En instance
Date de dépôt 2024-03-07
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for therapeutic use sold empty; medical syringe adapters and replacement parts and accessories therefor; medical fluid injectors

44.

TEVA

      
Numéro de série 98437909
Statut En instance
Date de dépôt 2024-03-07
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 10 - Appareils et instruments médicaux

Produits et services

Medical apparatus for facilitating the inhalation of pharmaceutical preparations; inhalers for therapeutic use sold empty; medical syringe adapters and replacement parts and accessories therefor; medical fluid injectors

45.

TEVA

      
Numéro de série 98437258
Statut En instance
Date de dépôt 2024-03-06
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Educational services, namely, conducting classes and seminars in the field of neurology, cancer, respiratory diseases and women's health

46.

Humanizing Health Awards

      
Numéro d'application 018938811
Statut Enregistrée
Date de dépôt 2023-10-18
Date d'enregistrement 2024-04-16
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

47.

HUMANISING HEALTH AWARDS

      
Numéro d'application 018937182
Statut Enregistrée
Date de dépôt 2023-10-13
Date d'enregistrement 2024-04-16
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

48.

HUMANIZING HEALTH AWARDS

      
Numéro d'application 018937227
Statut Enregistrée
Date de dépôt 2023-10-13
Date d'enregistrement 2024-04-16
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on-the-job initiatives to enhance patient and caregiver experience. Organisation of competitions and awards, namely, providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. Hosting a web site featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale.

49.

TEVA WE ARE ALL IN FOR BETTER HEALTH

      
Numéro d'application 018920168
Statut Enregistrée
Date de dépôt 2023-08-31
Date d'enregistrement 2024-01-24
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Human pharmaceutical preparations. Research services in the field of human pharmaceuticals.

50.

DEVICES AND METHODS FOR GASTRIC RETENTIVE DRUG DELIVERY

      
Numéro d'application 18023706
Statut En instance
Date de dépôt 2021-08-27
Date de la première publication 2023-08-31
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device for temporary residence in a stomach of a subject, the device carrying a load of an active pharmaceutical ingredient and having an expanded configuration. When the device is positioned in the stomach and in the expanded configuration, the device is configured to be retained in the stomach of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the pyloric valve. This enables dispensing locally therapeutic substances at a gastric region of a human body.

Classes IPC  ?

  • A61F 5/00 - Procédés ou dispositifs d'orthopédie pour le traitement non chirurgical d'os ou articulationsDispositifs pour donner des soins

51.

DEVICES FOR REGIO-SPECIFIC RELEASE OF CARRIED DRUG AT ILEOCECAL REGION

      
Numéro d'application 18023700
Statut En instance
Date de dépôt 2021-08-27
Date de la première publication 2023-08-31
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device (100) for temporary residence at an ileocecal valve of a subject, the device carrying a load of an active pharmaceutical ingredient (API) and having an expanded configuration. When the device is positioned at the ileocecal valve and in the expanded configuration, the device is configured to be retained at the ileocecal valve of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. This enables dispensing locally therapeutic substances at an ileocecal valve (ICV) region of a human body.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

52.

HUMANIZING HEALTH CARE

      
Numéro d'application 227161400
Statut En instance
Date de dépôt 2023-07-26
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ?
  • 35 - Publicité; Affaires commerciales
  • 41 - Éducation, divertissements, activités sportives et culturelles
  • 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

(1) Conducting incentive award programs for Non-Governmental Organizations to support and promote healthcare and on the job initiatives to enhance patient and caregiver experience. (2) Providing recognition and incentives by the way of contests and monetary awards to demonstrate excellence in the field of healthcare. (3) Providing software as a service (SaaS) featuring technology that enables companies and organizations to administer and manage employee incentive award programs and to promote employee productivity, performance, recognition and morale via a website.

53.

CENMIRA

      
Numéro de série 98079248
Statut En instance
Date de dépôt 2023-07-11
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of neurological disorders

54.

TEVA

      
Numéro de série 98042081
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Human Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract disorders, gastrointestinal and dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, cancer, central nervous system diseases, circulatory system diseases, sensory organ diseases, urogenital organ diseases, peripheral nervous system diseases, bone disorders and bone diseases; Human Pharmaceutical preparations, namely, injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations

55.

TEVA API

      
Numéro de série 98042078
Statut En instance
Date de dépôt 2023-06-14
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 35 - Publicité; Affaires commerciales

Produits et services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals Business management and business management consulting; public relations; business marketing consulting services; promotion services, namely, promoting the goods and services of others through dissemination of advertising materials on the Internet; business research services; providing business information to others in the field of pharmaceuticals

56.

Miscellaneous Design

      
Numéro de série 97927022
Statut En instance
Date de dépôt 2023-05-09
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 41 - Éducation, divertissements, activités sportives et culturelles

Produits et services

Training services for pharmacists in the field of pharmacy; Educational services, namely, conducting online classes and seminars for pharmacists in the fields of neurology, cancer, respiratory diseases and women's health

57.

TEVA

      
Numéro de série 97659009
Statut En instance
Date de dépôt 2022-11-02
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 09 - Appareils et instruments scientifiques et électriques

Produits et services

Downloadable software in the nature of a mobile application for providing an on-line database to provide patient health improvement in the field of pharmaceuticals, for pharmaceutical interaction analysis, and for treatment of adverse pharmaceutical interactions; Downloadable computer application software for mobile phones, namely, software for keeping track of pharmaceutical dosage schedules and injections; Downloadable computer software for tracking respiratory events and actions, controlling and managing patient medical information, identifying problems concerning adverse drug reactions, and enabling medical clinicians to monitor and manage drug related patient health data

58.

RETENTIVE DEVICES FOR GASTROINTESTINAL TRACT

      
Numéro d'application IB2022051815
Numéro de publication 2022/185220
Statut Délivré - en vigueur
Date de dépôt 2022-03-02
Date de publication 2022-09-09
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device (1000) for temporary residence at a predetermined location of the gastrointestinal tract of a subject, the device being configured to transfer from a closed configuration into an expanded configuration. The device is configured to be retained at said predetermined location of the subject. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to move past the predetermined location. This enables localized medical methods in the gastrointestinal tract of the subject.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps
  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus

59.

FIXED-DOSE PHARMACEUTICAL COMPOSITIONS

      
Numéro d'application IB2022051582
Numéro de publication 2022/180531
Statut Délivré - en vigueur
Date de dépôt 2022-02-23
Date de publication 2022-09-01
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD (Israël)
Inventeur(s)
  • Theurer, Marc
  • Steigerwald, Mario

Abrégé

The invention relates to fixed-dose pharmaceutical compositions comprising: • from 1 to 25 mg rivaroxaban or apixaban; • amlodipine, torasemide, bisoprolol or metoprolol; and • a pharmaceutically acceptable excipient. The invention also relates to their use in the treatment or prevention of stroke and systemic embolism, and the treatment and prevention of stroke and systemic embolism in patients with essential hypertension.

Classes IPC  ?

  • A61K 9/20 - Pilules, pastilles ou comprimés
  • A61K 9/24 - Pilules, pastilles ou comprimés du type à libération prolongée ou discontinue en doses unitaires constituées de couches ou feuilletées
  • A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
  • A61K 31/138 - Aryloxyalkylamines, p. ex. propranolol, tamoxifène, phénoxybenzamine
  • A61K 31/4422 - 1,4-Dihydropyridines, p. ex. nifédipine, nicardipine
  • A61K 31/4545 - Pipéridines non condensées, p. ex. pipérocaïne contenant d'autres systèmes hétérocycliques contenant un cycle à six chaînons avec l'azote comme hétéro-atome du cycle, p. ex. pipampérone, anabasine
  • A61K 31/5377 - 1,4-Oxazines, p. ex. morpholine non condensées et contenant d'autres hétérocycles, p. ex. timolol
  • A61K 31/64 - Sulfonylurées, p. ex. glibenclamide, tolbutamide, chlorpropamide
  • A61P 9/06 - Antiarythmiques
  • A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
  • A61P 9/12 - Antihypertenseurs

60.

DEVICES FOR REGIO-SPECIFIC RELEASE OF CARRIED DRUG AT ILEOCECAL REGION

      
Numéro d'application IB2021057884
Numéro de publication 2022/043948
Statut Délivré - en vigueur
Date de dépôt 2021-08-27
Date de publication 2022-03-03
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device (100) for temporary residence at an ileocecal valve of a subject, the device carrying a load of an active pharmaceutical ingredient (API) and having an expanded configuration. When the device is positioned at the ileocecal valve and in the expanded configuration, the device is configured to be retained at the ileocecal valve of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. This enables dispensing locally therapeutic substances at an ileocecal valve (ICV) region of a human body.

Classes IPC  ?

  • A61M 31/00 - Dispositifs pour l'introduction ou la rétention d'agents, p. ex. de remèdes, dans les cavités du corps

61.

DEVICES AND METHODS FOR GASTRIC RETENTIVE DRUG DELIVERY

      
Numéro d'application IB2021057886
Numéro de publication 2022/043950
Statut Délivré - en vigueur
Date de dépôt 2021-08-27
Date de publication 2022-03-03
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device for temporary residence in a stomach of a subject, the device carrying a load of an active pharmaceutical ingredient and having an expanded configuration. When the device is positioned in the stomach and in the expanded configuration, the device is configured to be retained in the stomach of the subject, and for releasing at least partially the active pharmaceutical ingredient while allowing chyme flow. The device is further configured to transfer from the expanded configuration into an emptying configuration in which the device is configured to pass through the pyloric valve. This enables dispensing locally therapeutic substances at a gastric region of a human body.

Classes IPC  ?

  • A61F 5/00 - Procédés ou dispositifs d'orthopédie pour le traitement non chirurgical d'os ou articulationsDispositifs pour donner des soins

62.

TEVACANN

      
Numéro d'application 018652399
Statut Enregistrée
Date de dépôt 2022-02-10
Date d'enregistrement 2022-06-15
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Oils containing cannabis (for cosmetic purposes). Cannabis based preparations for human use/ products containing cannabis for human use. Providing medical information relating to products containing cannabis.

63.

TEVACANN

      
Numéro d'application 216499300
Statut En instance
Date de dépôt 2022-02-08
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Cannabis oil for cosmetic purposes (2) Dietary supplements for humans containing cannabis for medicinal purposes. (1) Providing medical information relating to products containing cannabis.

64.

TEVACANN

      
Numéro de série 97253500
Statut En instance
Date de dépôt 2022-02-04
Propriétaire Teva Pharmaceutical Industries LTD (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Dietary supplements; vaporizers for medical purposes sold filled with hemp, excluding essential oils, for human use; all of the foregoing goods containing hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis and not containing CBD Providing medical information relating to products containing cannabis

65.

JUVIAND

      
Numéro d'application 018634885
Statut Enregistrée
Date de dépôt 2022-01-10
Date d'enregistrement 2022-05-11
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparation for treatment of oculars disease and disorders.

66.

ATTENUKINE

      
Numéro de série 97205484
Statut En instance
Date de dépôt 2022-01-06
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of cancer and autoimmune diseases

67.

Use of rasagiline for the treatment of restless legs syndrome

      
Numéro d'application 17399753
Numéro de brevet 12310929
Statut Délivré - en vigueur
Date de dépôt 2021-08-11
Date de la première publication 2021-12-16
Date d'octroi 2025-05-27
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES, LTD. (Israël)
Inventeur(s)
  • Blaugrund, Eran
  • Levy, Ruth

Abrégé

Disclosed are methods for the treatment of Restless Legs Syndrome comprising administering an amount of R(+)-N-propargyl-1-aminoindan or a pharmaceutically acceptable salt thereof.

Classes IPC  ?

  • A61K 31/135 - Amines, p. ex. amantadine ayant des cycles aromatiques, p. ex. méthadone
  • A61K 31/16 - Amides, p. ex. acides hydroxamiques
  • A61K 31/428 - Thiazoles condensés avec des carbocycles
  • A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
  • A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
  • A61P 25/08 - AntiépileptiquesAnticonvulsivants
  • A61P 25/14 - Médicaments pour le traitement des troubles du système nerveux pour traiter les mouvements anormaux, p. ex. chorée, dyskinésie
  • A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

68.

Injector pen

      
Numéro d'application 29660932
Numéro de brevet D0936824
Statut Délivré - en vigueur
Date de dépôt 2018-08-23
Date de la première publication 2021-11-23
Date d'octroi 2021-11-23
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Inventeur(s) Donnelly, Mathew

69.

Miscellaneous Design

      
Numéro d'application 018606310
Statut Enregistrée
Date de dépôt 2021-11-22
Date d'enregistrement 2022-04-12
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for human use.

70.

TRUXIMA DESIGN

      
Numéro d'application 214864300
Statut En instance
Date de dépôt 2021-11-19
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ?
  • 03 - Produits cosmétiques et préparations de toilette; préparations pour blanchir, nettoyer, polir et abraser.
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Human preparations.

71.

ONGAVIA

      
Numéro d'application 213132700
Statut Enregistrée
Date de dépôt 2021-09-02
Date d'enregistrement 2025-04-16
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

72.

ONGAVIA

      
Numéro d'application 018546382
Statut Enregistrée
Date de dépôt 2021-09-01
Date d'enregistrement 2021-12-29
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparation for treatment of oculars disease and disorders.

73.

LUCIAD

      
Numéro d'application 212197800
Statut En instance
Date de dépôt 2021-07-21
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

74.

ACIMAB

      
Numéro d'application 212198300
Statut Enregistrée
Date de dépôt 2021-07-21
Date d'enregistrement 2025-03-26
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

75.

MODYVANZ

      
Numéro d'application 212197600
Statut Enregistrée
Date de dépôt 2021-07-21
Date d'enregistrement 2025-03-26
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

76.

MAPTEV

      
Numéro d'application 212197900
Statut Enregistrée
Date de dépôt 2021-07-21
Date d'enregistrement 2025-03-26
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the treatment of Multiple Sclerosis, Lupus Nephritis and Crohn's Disease.

77.

EOSYNQ

      
Numéro de série 90817355
Statut En instance
Date de dépôt 2021-07-08
Propriétaire TEVA Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of inflammatory disorders

78.

MODYVANZ

      
Numéro d'application 018493951
Statut Enregistrée
Date de dépôt 2021-06-16
Date d'enregistrement 2021-10-16
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparation for treatment of oculars disease and disorders.

79.

MAPTEV

      
Numéro d'application 018494807
Statut Enregistrée
Date de dépôt 2021-06-16
Date d'enregistrement 2021-10-16
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparation for treatment of oculars disease and disorders.

80.

TEVA

      
Numéro de série 90615726
Statut Enregistrée
Date de dépôt 2021-03-31
Date d'enregistrement 2022-04-19
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 35 - Publicité; Affaires commerciales

Produits et services

Management services of business affairs and commercial functions of an industrial or commercial enterprise, namely, personnel recruitment, personnel management consultancy and accounting services; Business and marketing research, all in the field of pharmaceuticals

81.

TEVA

      
Numéro de série 90615708
Statut Enregistrée
Date de dépôt 2021-03-31
Date d'enregistrement 2022-04-19
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 35 - Publicité; Affaires commerciales

Produits et services

Management services of business affairs and commercial functions of an industrial or commercial enterprise, namely, personnel recruitment, personnel management consultancy and accounting services; Business and marketing research, all in the field of pharmaceuticals

82.

DEVICES AND METHODS FOR REGIO-SPECIFIC DRUG RELEASE AT ILEOCECAL REGION

      
Numéro d'application IL2020050941
Numéro de publication 2021/038572
Statut Délivré - en vigueur
Date de dépôt 2020-08-30
Date de publication 2021-03-04
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Ben Menachem, Avshalom
  • Zalit, Ilan

Abrégé

The present disclosure provides with a device for temporary residence at an ileocecal valve of a subject, the device having a trapping configuration, wherein in the trapping configuration, the device is configured to be retained at the ileocecal valve of the subject when the device is positioned at the ileocecal valve; comprises a trapping assembly configured for blocking a cooperating ingestible object while allowing chyme flow, when the device is positioned at the ileocecal valve; and the device being further configured to transfer from the trapping configuration into an emptying configuration in which the device is configured to pass through the ileocecal valve. The present disclosure further provides with oral dosage forms cooperating with the device for local dispensing of a therapeutic agent at the ileocecal valve region.

Classes IPC  ?

  • A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau

83.

TEVA

      
Numéro de série 90266118
Statut Enregistrée
Date de dépôt 2020-10-20
Date d'enregistrement 2023-12-19
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely, fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents affecting the central nervous system; Pharmaceutical agents affecting circulatory systems; Pharmaceutical agents affecting sensory organs; Pharmaceutical agents affecting urogenital organs; Pharmaceutical agents affecting peripheral nervous system

84.

FACE AU QUOTIDIEN

      
Numéro d'application 204494600
Statut Enregistrée
Date de dépôt 2020-08-11
Date d'enregistrement 2025-01-03
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

(1) Providing information and advice about diseases and disorders for patients and patient caregivers, namely, providing information and advice on the prevention and treatment of Alzheimer's disease, depression, psychological disorders, diabetes and diabetic neuropathy, cardiovascular and blood pressure disorders, irritable bowel syndrome, neurodegenerative diseases and disorders, osteoporosis, pain and neuropathic pain, peripheral nervous system diseases and disorders, digestive tract diseases and disorders, gastrointestinal diseases and disorders, dermatological diseases and disorders, respiratory system diseases and disorders, sexual dysfunction, symptoms associated with uterine fibroids, urinary incontinence and overactive bladder, AIDS-related disorders, loss of bone strength and bone health, bone disorders and bone disease, cancer, central nervous system diseases and disorders, circulatory systems diseases and disorders, diseases and disorders of the sensory organs, diseases and disorders of the urogenital organs, neurological disorders, and providing information and advice on the use of injectable contraceptives, contraceptive preparations, fertility enhancement preparations, and hormone replacement therapy preparations.

85.

TEVAPHARM

      
Numéro d'application 018285645
Statut Enregistrée
Date de dépôt 2020-08-06
Date d'enregistrement 2021-01-09
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 44 - Services médicaux, services vétérinaires, soins d'hygiène et de beauté; services d'agriculture, d'horticulture et de sylviculture.

Produits et services

Pharmaceutical preparations; medicines; dietetic substances adapted for medical use; dietetic foods adapted for medical purposes; nutritional additives for medical purposes; vitamin preparations; preparations of trace elements for human and animal use; mineral food supplements; bacterial preparations for medical use. Consulting services in the field of pharmaceuticals.

86.

S1P3 antagonists

      
Numéro d'application 16751472
Numéro de brevet 11472772
Statut Délivré - en vigueur
Date de dépôt 2020-01-24
Date de la première publication 2020-05-21
Date d'octroi 2022-10-18
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LIMITED (Israël)
Inventeur(s)
  • Caramelli, Chiara
  • Federico, Cesare
  • Gabellieri, Emanuele
  • Magnani, Matteo
  • Micco, Iolanda
  • Terstappen, Georg C.

Abrégé

The present invention relates to antagonists of the S1P3 receptor formula (A) as herein described and pharmaceutical compositions thereof. The compounds of formula (A) are useful in the preparation of a medicament, in particular for the treatment of Alzheimer's disease.

Classes IPC  ?

  • C07D 213/75 - Radicaux amino ou imino, acylés par un acide carboxylique, par l'acide carbonique ou par leurs analogues du soufre ou de l'azote, p. ex. des carbamates
  • C07D 403/12 - Composés hétérocycliques contenant plusieurs hétérocycles, comportant des atomes d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 401/12 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 413/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes d'azote et d'oxygène comme uniques hétéro-atomes du cycle contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 417/12 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant deux hétérocycles liés par une chaîne contenant des hétéro-atomes comme chaînons
  • C07D 241/16 - Atomes d'halogènesRadicaux nitro
  • C07D 277/32 - Composés hétérocycliques contenant des cycles thiazole-1, 3 ou thiazole-1, 3 hydrogénés non condensés avec d'autres cycles comportant deux ou trois liaisons doubles entre chaînons cycliques ou entre chaînons cycliques et chaînons non cycliques avec des hétéro-atomes ou avec des atomes de carbone comportant trois liaisons à des hétéro-atomes, avec au plus une liaison à un halogène, p. ex. radicaux ester ou nitrile, liés directement aux atomes de carbone du cycle
  • C07D 401/14 - Composés hétérocycliques contenant plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle, au moins un cycle étant un cycle à six chaînons avec un unique atome d'azote contenant au moins trois hétérocycles
  • C07D 405/14 - Composés hétérocycliques contenant à la fois un ou plusieurs hétérocycles comportant des atomes d'oxygène comme uniques hétéro-atomes du cycle et un ou plusieurs hétérocycles comportant des atomes d'azote comme uniques hétéro-atomes du cycle contenant au moins trois hétérocycles
  • C07D 417/14 - Composés hétérocycliques contenant plusieurs hétérocycles, au moins un cycle comportant des atomes de soufre et d'azote comme uniques hétéro-atomes du cycle, non prévus par le groupe contenant au moins trois hétérocycles

87.

TEVA

      
Numéro de série 88831374
Statut Enregistrée
Date de dépôt 2020-03-12
Date d'enregistrement 2020-12-29
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Research services in the field of pharmaceuticals

88.

MEDROXYPROGESTERONE ACETATE INJECTABLE COMPOSITIONS AND METHODS OF USE

      
Numéro d'application IB2019057537
Numéro de publication 2020/049521
Statut Délivré - en vigueur
Date de dépôt 2019-09-06
Date de publication 2020-03-12
Propriétaire TEVA PHARMACEUTICAL INDUSTRIES LTD. (Israël)
Inventeur(s)
  • Sundaramurthi, Prakash
  • Mijakovac, Ivana
  • Rasic, Andrea
  • Tunjic, Iva

Abrégé

The disclosure is directed to medroxyprogesterone compositions suitable for subcutaneous injection comprising about 260 mg/ml to 440 mg/ml medroxyprogesterone acetate, about 0.6 mg/ml to 1.5 mg/ml docusate sodium and, polyethylene glycol. Methods of using these compositions are also described.

Classes IPC  ?

  • A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
  • A61K 31/00 - Préparations médicinales contenant des ingrédients actifs organiques
  • A61K 47/02 - Composés inorganiques
  • A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
  • A61K 47/20 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant du soufre, p. ex. sulfoxyde de diméthyle [DMSO], docusate, laurylsulfate de sodium ou acides aminosulfoniques

89.

TEVA

      
Numéro de série 88829683
Statut Enregistrée
Date de dépôt 2020-03-11
Date d'enregistrement 2021-03-30
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals

90.

COPAXONE PEN

      
Numéro d'application 018188354
Statut Enregistrée
Date de dépôt 2020-01-27
Date d'enregistrement 2020-05-22
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 05 - Produits pharmaceutiques, vétérinaires et hygièniques
  • 10 - Appareils et instruments médicaux

Produits et services

Pharmaceutical preparations for the treatment of multiple sclerosis. Injection devices sold empty for use in the treatment of multiple sclerosis.

91.

IBREATHE

      
Numéro de série 88773994
Statut En instance
Date de dépôt 2020-01-27
Propriétaire Teva Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Pharmaceutical preparations for the treatment of respiratory diseases

92.

TEVA

      
Numéro de série 88749354
Statut Enregistrée
Date de dépôt 2020-01-07
Date d'enregistrement 2021-05-04
Propriétaire Teva Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture

Produits et services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemicals and chemical preparations for use in the manufacture of pharmaceuticals

93.

TEVA

      
Numéro de série 88749356
Statut Enregistrée
Date de dépôt 2020-01-07
Date d'enregistrement 2020-12-22
Propriétaire Teva Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 42 - Services scientifiques, technologiques et industriels, recherche et conception

Produits et services

Research services in the field of pharmaceuticals

94.

TEVA API

      
Numéro d'application 199899600
Statut Enregistrée
Date de dépôt 2019-12-03
Date d'enregistrement 2025-05-30
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 35 - Publicité; Affaires commerciales

Produits et services

(1) Bulk pharmaceutical chemicals and fine chemicals, namely, active chemical ingredients for use in the manufacture of pharmaceuticals; chemical additives and chemical preparations for use in the manufacture of pharmaceuticals. (1) Business management and business management consulting; public relations; business marketing consulting; promotional services, namely, promoting the goods and services of others through dissemination of advertising for others via the Internet; business research services; providing business information for developing marketing strategies for others in the field of pharmaceuticals.

95.

TEVA

      
Numéro de série 88663880
Statut Enregistrée
Date de dépôt 2019-10-22
Date d'enregistrement 2020-09-22
Propriétaire Teva Pharmaceutical Industries Limited (Israël)
Classes de Nice  ? 36 - Services financiers, assurances et affaires immobilières

Produits et services

Providing insurance information regarding access to enrollment and reimbursement programs for the purchase of medications; Providing information to patients about patient insurance reimbursement and insurance coverage for medications; Prescription drug insurance claims assistance services, namely, providing insurance information on patient reimbursement programs; Providing information regarding medical insurance benefits; Providing information on government and other third parties' financial assistance programs to assist in the purchase of medications

96.

teva api

      
Numéro d'application 018129964
Statut Enregistrée
Date de dépôt 2019-09-27
Date d'enregistrement 2020-01-25
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ?
  • 01 - Produits chimiques destinés à l'industrie, aux sciences ainsi qu'à l'agriculture
  • 35 - Publicité; Affaires commerciales

Produits et services

Bulk pharmaceutical chemicals and fine chemicals for use in the manufacture of pharmaceuticals; chemical and chemical preparations for use in the manufacture of pharmaceuticals. Business management and business management consulting; public relations; business marketing consulting; promotion services, namely, promoting the goods and services of others through dissemination of advertising materials on the Internet; business research services; providing business information to others in the field of pharmaceuticals.

97.

TEVA

      
Numéro d'application 198047000
Statut Enregistrée
Date de dépôt 2019-08-14
Date d'enregistrement 2024-09-09
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

98.

TEVA

      
Numéro d'application 198047100
Statut Enregistrée
Date de dépôt 2019-08-14
Date d'enregistrement 2024-09-09
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

99.

TEVA

      
Numéro d'application 198047200
Statut Enregistrée
Date de dépôt 2019-08-14
Date d'enregistrement 2024-09-09
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.

100.

TEVA

      
Numéro d'application 198047300
Statut Enregistrée
Date de dépôt 2019-08-14
Date d'enregistrement 2024-09-09
Propriétaire Teva Pharmaceutical Industries Ltd. (Israël)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

(1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.
  1     2     3     ...     8        Prochaine page